CALISTOGA PHARMACEUTICALS INC
SEATTLE, WA · Founded 2006 · CIK 0001385313 · Biotech · Acquired
Small molecule therapeutics for oncology and inflammatory diseases
calistogapharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $35M
- 3 Form D · Jul 2010
- 195 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820092010
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $14,999,999 | |
| Private capital raised | Form D · SEC | $19,281,219 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2447 | Spark2Flame, Inc | — | — |
| 2448 | Biohaven Pharmaceutical Holding Co Ltd. | — | $40M |
| 2449 | Ionetix Corp | — | $38M |
| 2450 | CALISTOGA PHARMACEUTICALS INC | — | $35M |
| 2451 | PROTEAN BIO INC. | — | — |
| 2452 | PALM THERAPEUTICS, INC. | — | — |
| 2453 | ILLUMINATE THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Aaron CoeExecutive Officer
- Robert DouglasDirector
- Carol GallagherDirector · Executive Officer
- W. GallatinDirector · Promoter
- W. Michael GallatinDirector · Executive Officer
- Andrew GuggenhimeExecutive Officer
- Ed HurwitzDirector
- Edward HurwitzDirector
- Richard LinDirector
- Langdon MillerExecutive Officer
- Clifford StocksExecutive Officer
- James TopperDirector · Executive Officer
Patents
- Methods Of Treatment For Solid Tumorsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.